ARCHIVES

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

This article is from The Cancer Letter archive.

Vol. 15 No. 32 | August 11, 1989

Download PDF Visit The Full Archive

Related Articles

ACS Research Budget Over $82 Million

July 17, 1987

Rauscher May Set Up New Office To Monitor, Coordinate RFPs And Grants, Stop Duplication

May 2, 1975

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

In Brief: Markup Of Cancer Act Renewal Bill Oct. 31; Garfinkel New ACS VP For Epidemiology

October 19, 1979

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012